Verónica Rivas

632 total citations
19 papers, 473 citations indexed

About

Verónica Rivas is a scholar working on Molecular Biology, Oncology and Immunology and Allergy. According to data from OpenAlex, Verónica Rivas has authored 19 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Immunology and Allergy. Recurrent topics in Verónica Rivas's work include Receptor Mechanisms and Signaling (6 papers), Protein Kinase Regulation and GTPase Signaling (3 papers) and Cell Adhesion Molecules Research (3 papers). Verónica Rivas is often cited by papers focused on Receptor Mechanisms and Signaling (6 papers), Protein Kinase Regulation and GTPase Signaling (3 papers) and Cell Adhesion Molecules Research (3 papers). Verónica Rivas collaborates with scholars based in Spain, Mexico and United States. Verónica Rivas's co-authors include Petronila Penela, Federico Mayor, Clara Reglero, Alicia Salcedo, Laura Nogués, María Neves, Catalina Ribas, Vanesa Lafarga, David Hardisson and Marta Mendiola and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

Verónica Rivas

19 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Verónica Rivas Spain 11 367 101 73 64 53 19 473
Helen M. Jopling United Kingdom 7 379 1.0× 85 0.8× 86 1.2× 114 1.8× 31 0.6× 7 460
Dorothea Tzvetkova‐Robev United States 7 355 1.0× 58 0.6× 176 2.4× 86 1.3× 36 0.7× 7 508
Xu Hou China 10 303 0.8× 58 0.6× 110 1.5× 69 1.1× 53 1.0× 29 531
Ikue Tai-Nagara Japan 7 246 0.7× 43 0.4× 52 0.7× 77 1.2× 49 0.9× 9 416
Nevenka Dudvarski Stanković Germany 5 197 0.5× 82 0.8× 42 0.6× 40 0.6× 82 1.5× 6 445
Jiao‐Hui Wu United States 14 394 1.1× 59 0.6× 116 1.6× 68 1.1× 88 1.7× 18 504
Rebekka M. Ortiz Finland 9 281 0.8× 146 1.4× 60 0.8× 59 0.9× 78 1.5× 11 572
Thierry Horner United States 11 536 1.5× 54 0.5× 105 1.4× 224 3.5× 43 0.8× 20 674
Yi‐Chinn Weng United States 9 525 1.4× 182 1.8× 25 0.3× 76 1.2× 39 0.7× 15 701
Alejandra Valdivia United States 16 297 0.8× 87 0.9× 60 0.8× 153 2.4× 95 1.8× 21 596

Countries citing papers authored by Verónica Rivas

Since Specialization
Citations

This map shows the geographic impact of Verónica Rivas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verónica Rivas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verónica Rivas more than expected).

Fields of papers citing papers by Verónica Rivas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Verónica Rivas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verónica Rivas. The network helps show where Verónica Rivas may publish in the future.

Co-authorship network of co-authors of Verónica Rivas

This figure shows the co-authorship network connecting the top 25 collaborators of Verónica Rivas. A scholar is included among the top collaborators of Verónica Rivas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Verónica Rivas. Verónica Rivas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Rivas, Verónica, et al.. (2024). GRK2-mediated AKT activation controls cell cycle progression and G2 checkpoint in a p53-dependent manner. Cell Death Discovery. 10(1). 385–385. 3 indexed citations
2.
Rivas, Verónica, et al.. (2023). Epidemiology of demyelinating diseases in Mexico: A registry-based study. Multiple Sclerosis and Related Disorders. 75. 104753–104753. 2 indexed citations
3.
Reglero, Clara, et al.. (2021). Mdm2-Mediated Downmodulation of GRK2 Restricts Centrosome Separation for Proper Chromosome Congression. Cells. 10(4). 729–729. 2 indexed citations
4.
Reglero, Clara, Vanesa Lafarga, Verónica Rivas, et al.. (2020). GRK2-Dependent HuR Phosphorylation Regulates HIF1α Activation under Hypoxia or Adrenergic Stress. Cancers. 12(5). 1216–1216. 15 indexed citations
5.
Ordóñez, Graciela, Verónica Rivas, Marcos Santos, et al.. (2019). Herpes viruses in optic neuritis: Similar to Bell’s palsy. Clinical Neurology and Neurosurgery. 188. 105588–105588. 2 indexed citations
6.
Monroy‐Jaramillo, Nancy, et al.. (2018). Phenotypic Variability in a Mexican Mestizo Family with Retinal Vasculopathy with Cerebral Leukodystrophy and TREX1 Mutation p.V235Gfs*6. Revista de investigaci�n Cl�nica. 70(2). 68–75. 5 indexed citations
7.
Nogués, Laura, Clara Reglero, Verónica Rivas, et al.. (2017). G protein-coupled receptor kinases (GRKs) in tumorigenesis and cancer progression: GPCR regulators and signaling hubs. Seminars in Cancer Biology. 48. 78–90. 68 indexed citations
8.
Nogués, Laura, Clara Reglero, Verónica Rivas, et al.. (2016). G-Protein–Coupled Receptor Kinase 2 as a Potential Modulator of the Hallmarks of Cancer. Molecular Pharmacology. 91(3). 220–228. 34 indexed citations
9.
Torre-Villalvazo, Iván, et al.. (2016). Epigenetics in Multiple Sclerosis: Molecular Mechanisms and Dietary Intervention. Central Nervous System Agents in Medicinal Chemistry. 18(1). 8–15. 12 indexed citations
10.
Nogués, Laura, Clara Reglero, Verónica Rivas, et al.. (2016). G Protein-coupled Receptor Kinase 2 (GRK2) Promotes Breast Tumorigenesis Through a HDAC6-Pin1 Axis. EBioMedicine. 13. 132–145. 56 indexed citations
11.
Rivas, Verónica, Laura Nogués, Clara Reglero, Federico Mayor, & Petronila Penela. (2014). Role of G protein-coupled receptor kinase 2 in tumoral angiogenesis. Molecular & Cellular Oncology. 1(4). e969166–e969166. 7 indexed citations
12.
Rivas, Verónica, Rita Carmona, Marta Mendiola, et al.. (2013). Developmental and tumoral vascularization is regulated by G protein–coupled receptor kinase 2. Journal of Clinical Investigation. 123(11). 4714–4730. 46 indexed citations
13.
14.
Rivas, Verónica, et al.. (2012). 346 Role of GRK2 in Developing Vasculature and Pathological Angiogenesis. European Journal of Cancer. 48. S84–S84. 2 indexed citations
15.
16.
Penela, Petronila, Verónica Rivas, Alicia Salcedo, & Federico Mayor. (2009). G protein–coupled receptor kinase 2 (GRK2) modulation and cell cycle progression. Proceedings of the National Academy of Sciences. 107(3). 1118–1123. 68 indexed citations
17.
Penela, Petronila, Cristina Murga, Catalina Ribas, et al.. (2008). G protein-coupled receptor kinase 2 (GRK2) in migration and inflammation. Archives of Physiology and Biochemistry. 114(3). 195–200. 17 indexed citations
18.
19.
García, Marta, Verónica Rivas, Marta Carretero, et al.. (2004). Inhibition of Xenografted Human Melanoma Growth and Prevention of Metastasis Development by Dual Antiangiogenic/Antitumor Activities of Pigment Epithelium-Derived Factor. Cancer Research. 64(16). 5632–5642. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helen M. Jopling Breakdown of academic impact, for papers by Dorothea Tzvetkova‐Robev Breakdown of academic impact, for papers by Xu Hou Breakdown of academic impact, for papers by Ikue Tai-Nagara Breakdown of academic impact, for papers by Nevenka Dudvarski Stanković Breakdown of academic impact, for papers by Jiao‐Hui Wu Breakdown of academic impact, for papers by Rebekka M. Ortiz Breakdown of academic impact, for papers by Thierry Horner Breakdown of academic impact, for papers by Yi‐Chinn Weng Breakdown of academic impact, for papers by Alejandra Valdivia
Rankless by CCL
2026